Navigation Links
GENSPEED Biotech and axiVEND Announce a Collaboration Agreement
Date:8/1/2019

The GENSPEED platform is a compact, fast and simple system to enable multiplex testing at the point of care. It is fully developed with over 100 units deployed in the field for multiple applications. “Beyond the creation of new tests, with applications into new fields of use, our collaboration with axiVEND will give us a foothold in the USA to better support other nascent test development opportunities,” said Max Sonnleitner, GENSPEED Biotech CEO. “We are excited about our collaboration with axiVEND and the expanded reach this will provide us.”

“The platform itself is very promising, leveraging simple microfluidic consumables and associated ease of use,” said Claude Dufresne, axiVEND CEO. “This platform gives us the fastest and best probability of success to bring novel multiplex test ideas to the market. We will market the new tests under the brand axiTESTtm and use the GENSPEED platform as an OEM system, branded with axiTESTtm colors. This is an exciting phase for both companies.”

About GENSPEED Biotech
GENSPEED Biotech was founded in 2016 as a spin-off company of Greiner Bio-One. We develop, produce and distribute IVD-certified rapid testing solutions based on the patented GENSPEED® technology.. Currently, nine highly qualified employees are devoted to the development, production and sales of in-vitro diagnostics for the rapid identification of various pathogens. With its novel combination of microfluidics, miniaturized opto-electronics and automation GENSPEED® enables the simultaneous detection of multiple analytes at the point of care within a few minutes. GENSPEED® may be used for nucleic acid-based genetic testing as well as for protein analyses. Thus, the platform facilitates the rapid identification of defined bacteria or viruses as well as the quantitation of certain biomarkers in blood or other biological material. For additional information please visit http://www.genspeed-biotech.com.

About axiVEND
While newly founded in 2019, axiVEND is built on the concept of truth in vending. From the Greek “axios” for truthfulness, axiVEND promises to provide the very best solutions, with proven field performance, to the worlds of diagnostics and multiplex assays. Leveraging an expanded network throughout North and South America, axiVEND will soon be positively impacting life science industries in general. The early axiVEND portfolio encompasses best-in-class M2 Automation ultra-low volume high-precision liquid deposition technologies, the latest offerings in colorimetric and fluorescence multiplex array readers, unique high-performance surface coatings for superior protein functional activity, and the next generation label-free multiplex reader. For additional information please visit the axiVEND website at http://www.axivend.com, and follow us on LinkedIn.

Read the full story at https://www.prweb.com/releases/genspeed_biotech_and_axivend_announce_a_collaboration_agreement/prweb16479709.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. KMK Consulting, Inc. Expands Presence in Boston to Help Biotechnology Companies from Pre-Launch to Commercialization
2. Lifecycle Biotechnologies Announces Cellular Agriculture Expansion
3. Swiss Biotech Gnubiotics, Announces Global Launch of GNU100 the First Microbiome Specialty Ingredient for Companion Animal Gut Health
4. Jessica Wein Joins Lifecycle Biotechnologies As Marketing Strategist
5. Peer-Reviewed Paper in Frontiers in Bioengineering and Biotechnology Reveals that uBiome Has the Largest Patent Portfolio in the Microbiome Space
6. Lifecycle Biotechnologies Announces Promotion of Cindy Baptiste to Business Development Manager
7. Lifecycle Biotechnologies Releases Company Catalog
8. Lifecycle Biotechnologies Launches 100-Liter SAFEthread Drum
9. Avastus Opens New Vivarium to Serve the Preclinical Research Needs of Boston’s Biotech Community
10. Biotech Automation and FDA Validation Expert Superior Controls to Exhibit and Recruit at the ISPE Annual Premier One-Day Biopharmaceutical Show on September 26
11. Dickinson Wright Attorney Lance Anderson Named Pharmaceuticals and Biotechnology Practice Group Chair
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/3/2019)... ... October 02, 2019 , ... Connecticut Innovations ... ongoing support for Connecticut’s innovative, growing companies, today announced that it has closed ... payments and winner of the 2018 VentureClash competition. , The ...
(Date:9/30/2019)... FREDERICK, Md. (PRWEB) , ... ... ... a biotechnology market disrupter and leading supplier of innovative human mesenchymal stem/stromal ... Australia for novel product formulations related to “Ready-to-Print” (RTP) cellular product formats ...
(Date:9/25/2019)... (PRWEB) , ... September 25, 2019 , ... ... biopharma leaders through off-the-record collaboration and dialogue, today announces its inaugural South ... Orleans BioInnovation Center in Louisiana. , Co-produced by Tulane University, this invitation-only ...
Breaking Biology News(10 mins):
(Date:9/22/2019)... ... September 20, 2019 , ... ... Neurotrophic Factor (BDNF) testing in serum . BDNF plays a vital role in ... growth and differentiation of new neurons in the brain involved in learning, memory, ...
(Date:9/17/2019)... ... September 17, 2019 , ... Jennifer Hermansky and ... have been named to Law360’s 2019 Rising Stars. Hermansky and Xie, named an Immigration ... from 1,300 submissions, spanning 39 practice areas. The list highlights attorneys “whose legal accomplishments ...
(Date:9/11/2019)... ... September 09, 2019 , ... Tunnell Consulting, ... agencies, announced that its president and CEO Maryann Gallivan has been accepted into ... The Forbes Council accepted Gallivan based on the role she and Tunnell ...
(Date:9/9/2019)... , ... September 09, 2019 , ... Visikol CEO Dr. ... that was focused on how best to characterize 3D cell culture models. The inherent ... they are too thick and opaque to image through and therefore traditional wide-field or ...
Breaking Biology Technology: